Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Apr 24, 2021 4:27pm
117 Views
Post# 33062116

RE:RE:RE:TH's website issues

RE:RE:RE:TH's website issuesI have to believe the chances of such an outcome are pretty high and hope that is how it plays out. But we await them being willing to speak to Wino and for Wino to report back to us all. If they are not willing to speak with him (I would be surprised if that were the case) or if he comes away concerned rather than relieved, then we will have to give a hard think as to how to vote.

Lee430 wrote: Perhaps after Wino has had a chance to speak/Zoom with Thera we will hear there is a master plan currently being executed that puts our concerns to rest, then we can douse the flaming torches and return our pitch forks to the barn….In the mean time I have finally received all of my proxy material today and ready to vote with this board. 


SPCEO1 wrote: It is a head scratcher. They are looking for an It director - could they be waiting to hire that person before acting? Hopefully not.
jeffm34 wrote: The lack of a decent website is such a glaring issue yet one of the easiest to fix.  Any ideas why the refuse to do anything about it?  It's almost as if they are refusing to out of spite because some people dared to suggest they could be doing a better job.  I think that is a prevailing attitude when it comes to doing business at TH. 

 




<< Previous
Bullboard Posts
Next >>